APA (7th ed.) Citation

Suzuki, Y., & Ishihara, H. (2021). Difference in the lipid nanoparticle technology employed in three approved siRNA (Patisiran) and mRNA (COVID-19 vaccine) drugs. Drug metabolism and pharmacokinetics, 41, 100424. https://doi.org/10.1016/j.dmpk.2021.100424

Chicago Style (17th ed.) Citation

Suzuki, Yuta, and Hiroshi Ishihara. "Difference in the Lipid Nanoparticle Technology Employed in Three Approved SiRNA (Patisiran) and MRNA (COVID-19 Vaccine) Drugs." Drug Metabolism and Pharmacokinetics 41 (2021): 100424. https://doi.org/10.1016/j.dmpk.2021.100424.

MLA (9th ed.) Citation

Suzuki, Yuta, and Hiroshi Ishihara. "Difference in the Lipid Nanoparticle Technology Employed in Three Approved SiRNA (Patisiran) and MRNA (COVID-19 Vaccine) Drugs." Drug Metabolism and Pharmacokinetics, vol. 41, 2021, p. 100424, https://doi.org/10.1016/j.dmpk.2021.100424.